human | Q5 |
P496 | ORCID iD | 0000-0002-1982-6879 |
P108 | employer | International Centre for Diarrhoeal Disease Research, Bangladesh | Q2945843 |
P106 | occupation | researcher | Q1650915 |
Q94116783 | 2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study |
Q28396900 | A prospective cohort study of stroke mortality and arsenic in drinking water in Bangladeshi adults |
Q90128017 | A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants |
Q64119992 | Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial |
Q52579975 | Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults. |
Q36314435 | Assessment of population structure and major circulating phylogeographical clades of Mycobacterium tuberculosis complex in Bangladesh suggests a high prevalence of a specific subclade of ancient M. tuberculosis genotypes |
Q112638071 | Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study |
Q89999663 | Can Cholera "Hotspots" be Converted to Cholera "Coldspots" in Cholera Endemic Countries? The Matlab, Bangladesh Experience |
Q99610117 | Can existing improvements of water, sanitation, and hygiene (WASH) in urban slums reduce the burden of typhoid fever in these settings? |
Q95848107 | Case Report: Salmonella Enterica Serovar Paratyphi B Infection in a Febrile Ill Child during Enhanced Passive Surveillance in an Urban Slum in Mirpur, Dhaka |
Q91885915 | Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine |
Q43171288 | Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial |
Q40128598 | Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study |
Q92213390 | Complex task to estimate immune responses to various poliovirus vaccines and vaccination schedules |
Q92056426 | Corrigendum to "Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study" [Vaccine 37 (2019) 4275-4280] |
Q56920752 | Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study |
Q39710479 | Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh |
Q34669133 | Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414. |
Q41206694 | Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial |
Q33781579 | Factors associated with poor knowledge among adults on tuberculosis in Bangladesh: results from a nationwide survey |
Q92781216 | HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh |
Q91729311 | Health Concerns in Urban Slums: A Glimpse of Things to Come? |
Q57470308 | Health seeking behaviour and delayed management of tuberculosis patients in rural Bangladesh |
Q64124152 | Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial |
Q41654818 | Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial |
Q51783086 | Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial. |
Q47255848 | Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A pha |
Q34575952 | Increased childhood mortality and arsenic in drinking water in Matlab, Bangladesh: a population-based cohort study |
Q58823336 | Influenza Immunization in Pregnancy — Antibody Responses in Mothers and Infants |
Q38501139 | Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh |
Q39940156 | Intussusception surveillance in a rural demographic surveillance area in bangladesh |
Q56888929 | Is Higher Viral Load in the Upper Respiratory Tract Associated With Severe Pneumonia? Findings From the PERCH Study |
Q47303982 | Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh |
Q57927674 | Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons |
Q98508243 | Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata |
Q28474022 | Pulmonary tuberculosis and drug resistance in Dhaka central jail, the largest prison in Bangladesh |
Q91278176 | Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial |
Q40404190 | Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh |
Q90686521 | Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial |
Q98162155 | Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants |
Q35102554 | Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh |
Q92997256 | Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study |
Q95650950 | Sequential inactivated and oral poliovirus vaccine schedules: a balancing act |
Q34427810 | Socio economic position in TB prevalence and access to services: results from a population prevalence survey and a facility-based survey in Bangladesh. |
Q39645266 | Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine |
Q102206007 | The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks |
Q38695279 | The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys |
Q90870148 | The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation |
Q40263982 | The effect of exclusive breast-feeding on respiratory illness in young infants in a maternal immunization trial in Bangladesh |
Q64124048 | The predictive performance of a pneumonia severity score in HIV-negative children presenting to hospital in seven low and middle-income countries |
Q36131945 | Two Generations of "Gold Standards": The Impact of a Decade in Hepatitis E Virus Testing Innovation on Population Seroprevalence |
Q64982832 | Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial. |
Q96689995 | Use of Typhoid Vi-Polysaccharide Vaccine as a Vaccine Probe to Delineate Clinical Criteria for Typhoid Fever |
Q64095027 | Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera |
Q42249800 | Vaccine for prevention of mild and moderate-to-severe influenza in children |
Search more.